Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Neuroimmunology

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JNEUROIM.2007.07.001PMID 17673301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti‐MuSK‐positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles

  2007cited by this paper
• Single‐fiber electromyography shows terminal axon dysfunction in Miller Fisher syndrome: A case report

  2006influential reference
• Progression of progressive multifocal leukoencephalopathy despite treatment with β-interferon

  2006cited by this paper
• Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis

  2005cited by this paper
• Concanavalin a inhibits pathophysiological effects of anti‐ganglioside GQ1b antibodies at the mouse neuromuscular synapse

  2005cited by this paper
• Electrophysiological evidence by single fibre electromyography of neuromuscular transmission impairment in a case of Miller Fisher syndrome

  2005cited by this paper
• Anti‐disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions

  2005influential reference
• Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi

  2004influential reference
• Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome

  2004cited by this paper
• Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome.

  2003cited by this paper
• Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.

  2003cited by this paper
• The relation of clinical symptoms and anti‐ganglioside antibodies to MEPPs frequency increase in 8 cases of variant type Guillain‐Barré syndrome

  2003cited by this paper
• Dysfunction at the motor end‐plate and axon membrane in Guillain–Barré syndrome: A single‐fiber EMG study

  2003cited by this paper
• Presynaptic neuromuscular transmission block in Guillain-Barré syndrome associated with anti-GQ1b antibodies.

  2002cited by this paper
• Detection and prevalence of α‐latrotoxin–like effects of serum from patients with Guillain–Barré syndrome

  2002cited by this paper
• Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction.

  2002cited by this paper
• Peripheral neuropathies and anti-glycolipid antibodies.

  2002cited by this paper
• Clinical impact of single‐fiber electromyography

  2002cited by this paper
• Fine specificity of anti-GQ1b IgG and clinical features.

  2001cited by this paper
• Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal.

  2001cited by this paper
• Axonal Guillain‐Barré syndrome: Relation to anti‐ganglioside antibodies and Campylobacter jejuni infection in Japan

  2000cited by this paper
• Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome

  2000cited by this paper
• Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: Relation to Miller Fisher syndrome

  2000cited by this paper
• Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block.

  1999cited by this paper
• Miller Fisher anti‐GQ1b antibodies: α‐Latrotoxin–like effects on motor end plates

  1999cited by this paper
• Fisher Syndrome with tetraparesis and antibody to GQ1b: Evidence for motor nerve terminal block

  1999cited by this paper
• Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates.

  1999cited by this paper
• Pre‐ and postsynaptic blockade of neuromuscular transmission by Miller–Fisher syndrome IgG at mouse motor nerve terminals

  1998cited by this paper
• Neuromuscular blockade by IgG antibodies from patients with Guillain‐Barré syndrome: A macro‐patch‐clamp study

  1998cited by this paper
• Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.

  1995cited by this paper
• Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release.

  1994cited by this paper
• Serum anti‐GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndrome

  1993cited by this paper
• Jitter measurement by axonal micro-stimulation. Guidelines and technical notes.

  1992cited by this paper
• Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

  1992influential reference

• Focal forms of acute polyradiculoneuritis

  2018cites this paper
• Varianty akutní polyradikuloneuritidy

  2018cites this paper
• Miller fisher syndrome – four case reports and review of current concept

  2018cites this paper
• Electrophysiology in Fisher syndrome.

  2017cites this paper
• The motor nerve terminal is a novel regulator of anti-ganglioside antibodies in mouse models of autoimmune neuropathy

  2015cites this paper
• The pre‐synaptic motor nerve terminal as a site for antibody‐mediated neurotoxicity in autoimmune neuropathies and synaptopathies

  2014cites this paper
• Miller Fisher syndrome with presynaptic neuromuscular transmission disorder.

  2014cites this paper
• Pharyngeal-cervical-brachial variant of Guillain–Barré syndrome

  2013cites this paper
• Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy.

  2012cites this paper
• Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings

  2012cites this paper
• Abnormalities of neuromuscular transmission in patients with Miller-Fisher syndrome.

  2012cites this paper
• Heterodimeric glycolipid complexes as targets for neuropathy associated pathogenic autoantibodies and other lectins

  2012cites this paper
• Fisher syndrome: clinical features, immunopathogenesis and management

  2012cites this paper
• The role of endotoxin in infection: Helicobacter pylori and Campylobacter jejuni.

  2010cites this paper
• Neuromuscular transmission is not impaired in axonal Guillain–Barré syndrome

  2010cites this paper
• Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome).

  2009cites this paper
• Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junction

  2009cites this paper
• Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

  2009cites this paper
• IgM anti-GQ1b monoclonal antibody inhibits voltage-dependent calcium current in cerebellar granule cells.

  2009cites this paper
• Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles.

  2009cites this paper
• Molecular mimicry of host glycosylated structures by bacteria

  2009cites this paper
• Recurrent facial nerve palsy associated with anti-GQ1b IgG antibodies.

  2008cites this paper
• Ganglioside antibodies and neuropathies

  2008cites this paper